Announced
Completed
Financials
Tags
life sciences tools
Minority
Friendly
Private Equity
Completed
Private
Single Bidder
Acquisition
Venture Capital
Singapore
Medical Equipment
Cross Border
Synopsis
CIC Capital, Novo and Vivo Capital led a $200m Series A round in Esco Lifesciences Group, a provider of life sciences tools and services, with participation from EDBI. The financing will enable Esco to strengthen its position through organic and external growth and transformation, as well as invest in China, thus addressing some of the most dynamic market segments and geographies.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.